Total synthesis and structural validation of cyclodepsipeptides solonamide A and B
暂无分享,去创建一个
[1] L. Gram,et al. Solonamide B Inhibits Quorum Sensing and Reduces Staphylococcus aureus Mediated Killing of Human Neutrophils , 2014, PloS one.
[2] Kieron M. G. O'Connell,et al. Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials. , 2013, Angewandte Chemie.
[3] C. Olsen,et al. Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E. , 2013, Journal of medicinal chemistry.
[4] Vipin Chandra Kalia,et al. Quorum sensing inhibitors: an overview. , 2013, Biotechnology advances.
[5] A. Venkatesham,et al. Stereoselective total synthesis of stagonolide-C , 2012 .
[6] M. Ghadiri,et al. Macrocyclic peptoid-Peptide hybrids as inhibitors of class I histone deacetylases. , 2012, ACS medicinal chemistry letters.
[7] M. Ghadiri,et al. Discovery of HDAC Inhibitors That Lack an Active Site Zn(2+)-Binding Functional Group. , 2012, ACS medicinal chemistry letters.
[8] A. Venkatesham,et al. Stereoselective synthesis towards verbalactone and (+)-(3R,5R)-3-hydroxy-5-decanolide , 2012 .
[9] L. Gram,et al. Inhibition of Virulence Gene Expression in Staphylococcus aureus by Novel Depsipeptides from a Marine Photobacterium , 2011, Marine drugs.
[10] J. M. Takacs,et al. Catalytic asymmetric hydroboration of β,γ-unsaturated Weinreb amides: striking influence of the borane. , 2011, Chemical communications.
[11] D. Sturdevant,et al. Role of the Accessory Gene Regulator agr in Community-Associated Methicillin-Resistant Staphylococcus aureus Pathogenesis , 2011, Infection and Immunity.
[12] M. Otto. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. , 2010, Annual review of microbiology.
[13] V. Sperandio,et al. Anti-virulence strategies to combat bacteria-mediated disease , 2010, Nature Reviews Drug Discovery.
[14] M. Ghadiri,et al. Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides. , 2009, Journal of medicinal chemistry.
[15] H. Ingmer,et al. Method for Screening Compounds That Influence Virulence Gene Expression in Staphylococcus aureus , 2009, Antimicrobial Agents and Chemotherapy.
[16] F. DeLeo,et al. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. , 2009, The Journal of clinical investigation.
[17] Henry F. Chambers,et al. Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.
[18] John M. Beierle,et al. Design, synthesis, biological evaluation, and structural characterization of potent histone deacetylase inhibitors based on cyclic alpha/beta-tetrapeptide architectures. , 2009, Journal of the American Chemical Society.
[19] A. Ganesan,et al. Macrolactamization versus macrolactonization: total synthesis of FK228, the depsipeptide histone deacetylase inhibitor. , 2008, The Journal of organic chemistry.
[20] P. Skaanderup,et al. Synthesis of the macrocyclic core of (-)-pladienolide B. , 2008, Organic letters.
[21] J. Yadav,et al. A Concise Stereoselective Total Synthesis of Herbarumin III , 2008 .
[22] A. Clatworthy,et al. Targeting virulence: a new paradigm for antimicrobial therapy , 2007, Nature Chemical Biology.
[23] T. Muir,et al. Molecular Mechanisms of agr Quorum Sensing in Virulent Staphylococci , 2007, Chembiochem : a European journal of chemical biology.
[24] A. Ganesan,et al. Total synthesis of azumamide A and azumamide E, evaluation as histone deacetylase inhibitors, and design of a more potent analogue. , 2007, Organic letters.
[25] Hiroshi Tomoda,et al. Synthesis and biological evaluation of a beauveriolide analogue library. , 2006, Journal of combinatorial chemistry.
[26] J. Schmid,et al. A Broad Diversity of Volatile Carboxylic Acids, Released by a Bacterial Aminoacylase from Axilla Secretions, as Candidate Molecules for the Determination of Human‐Body Odor Type , 2006, Chemistry & biodiversity.
[27] H. Lode,et al. Management of serious nosocomial bacterial infections: do current therapeutic options meet the need? , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[28] M. Masnyk,et al. Dirhodium tetraacetate as an auxiliary chromophore in a circular dichroic study on vic-amino alcohols , 2005 .
[29] K. Anstrom,et al. Staphylococcus aureus endocarditis: a consequence of medical progress. , 2005, JAMA.
[30] S. Solomon,et al. Methicillin-resistant–Staphylococcus aureus Hospitalizations, United States , 2005, Emerging infectious diseases.
[31] D. M. Muñoz,et al. Assembly intermediates in polyketide biosynthesis: enantioselective syntheses of beta-hydroxycarbonyl compounds. , 2005, Organic & biomolecular chemistry.
[32] P. Schlievert,et al. Virulence regulation in Staphylococcus aureus: the need for in vivo analysis of virulence factor regulation. , 2004, FEMS immunology and medical microbiology.
[33] M. N. Reddy,et al. Toward homogeneity of chirality via selective formation of homochiral or heterochiral aggregates. , 2004, Organic letters.
[34] R. Novick. Autoinduction and signal transduction in the regulation of staphylococcal virulence , 2003, Molecular microbiology.
[35] C. Holmquist,et al. A selective method for the direct conversion of aldehydes into .beta.-keto esters with ethyl diazoacetate catalyzed by tin(II) chloride , 1989 .
[36] M. Braun,et al. Stereoselektive Aldolreaktionen mit (R)‐ und (S)‐(2‐Hydroxy‐1,2,2‐triphenylethyl)acetat und verwandten Glycolmonoacetaten , 1988 .
[37] M. Hiramoto,et al. The structure of viscosin, a peptide antibiotic. I. Syntheses of D- and L-3-hydroxyacyl-L-leucine hydrazides related to viscosin. , 1971, Chemical & pharmaceutical bulletin.
[38] G. Marshall,et al. The biology and future prospects of antivirulence therapies , 2008, Nature Reviews Microbiology.
[39] M. O'Reilly,et al. Regulation of exoprotein gene expression in Staphylococcus aureus by agr , 2004, Molecular and General Genetics MGG.
[40] F. Tenover,et al. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. , 1999, Emerging infectious diseases.
[41] A. Bernardi,et al. Ethyl-(r)-(4-methylphenylsulfinyl)-n-methoxy acetimidate a useful chiral acetate equivalent in aldol type condensations , 1984 .